These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25848481)

  • 1. Role of diet on non-alcoholic fatty liver disease: An updated narrative review.
    Papandreou D; Andreou E
    World J Hepatol; 2015 Mar; 7(3):575-82. PubMed ID: 25848481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of diet in non-alcoholic fatty liver disease].
    Jun DW
    Korean J Gastroenterol; 2013 May; 61(5):243-51. PubMed ID: 23756665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content.
    Siddiqui RA; Xu Z; Harvey KA; Pavlina TM; Becker MJ; Zaloga GP
    Nutr Metab (Lond); 2015; 12():41. PubMed ID: 26583036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance.
    Yki-Järvinen H
    Nutrients; 2015 Nov; 7(11):9127-38. PubMed ID: 26556368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease: The diagnosis and management.
    Abd El-Kader SM; El-Den Ashmawy EM
    World J Hepatol; 2015 Apr; 7(6):846-58. PubMed ID: 25937862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review.
    Pixner T; Stummer N; Schneider AM; Lukas A; Gramlinger K; Julian V; Thivel D; Mörwald K; Maruszczak K; Mangge H; Gomahr J; Weghuber D; Furthner D
    Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dietetary recommendation for non-alcoholic fatty liver disease].
    Jeznach-Steinhagen A; Ostrowska J; Czerwonogrodzka-Senczyna A; Boniecka I; Gronostajska W
    Pol Merkur Lekarski; 2017 Dec; 43(258):281-286. PubMed ID: 29298969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on non-alcoholic fatty liver disease in children.
    Papandreou D; Rousso I; Mavromichalis I
    Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.
    Moore JB
    Proc Nutr Soc; 2019 Aug; 78(3):290-304. PubMed ID: 30924429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
    Arendt BM; Teterina A; Pettinelli P; Comelli EM; Ma DWL; Fung SK; McGilvray ID; Fischer SE; Allard JP
    Nutrition; 2019 Jun; 62():100-107. PubMed ID: 30870804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.
    Yousef MH; Al Juboori A; Albarrak AA; Ibdah JA; Tahan V
    World J Gastrointest Pathophysiol; 2017 Aug; 8(3):100-107. PubMed ID: 28868179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats.
    Jeyapal S; Putcha UK; Mullapudi VS; Ghosh S; Sakamuri A; Kona SR; Vadakattu SS; Madakasira C; Ibrahim A
    Eur J Nutr; 2018 Sep; 57(6):2171-2187. PubMed ID: 28676973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of nutrition in non-alcoholic fatty liver disease treatment in obese children.
    Guimber D; Debray D; Bocquet A; Briend A; Chouraqui JP; Darmaun D; Feillet F; Frelut ML; Hankard R; Lapillonne A; Peretti N; Rozé JC; Simeoni U; Turck D; Dupont C; Comité de Nutrition de la Société Française de Pédiatrie Cnsfp
    Arch Pediatr; 2022 Jan; 29(1):1-11. PubMed ID: 34758930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
    Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
    Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.